Search

everythinglearnresearchcommunity

for

Search:↓

Distinguishing drug-induced lupus from systemic lupus is challenging and requires careful monitoring.

Membership in a self-help organization is linked to being better informed and having a higher education, but it doesn't clearly affect disease outcomes.

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Equisetum arvense extract in gels may enhance drug release for treatments.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

Cedrol may help treat rheumatoid arthritis due to its anti-inflammatory and antioxidant effects.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Methotrexate is effective for rheumatoid arthritis but can cause side effects.

Leflunomide is effective for rheumatoid arthritis but has significant side effects.

Rhupus is a complex syndrome that combines rheumatoid arthritis and lupus, making diagnosis challenging.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

A patient lost all their hair while on rheumatoid arthritis medication.

Long non-coding RNA Xist plays a key role in sex bias in lupus and rheumatoid arthritis, especially in females.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

Chinese patients with systemic lupus erythematosus commonly experience oral ulcers, arthritis, alopecia, skin rash, and nephritis.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

SLE is more common among Nigerians than previously thought, especially in women, requiring early treatment.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Anti-TNF therapy can cause weight gain and hair loss, leading some patients to stop treatment.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

A Nigerian teenager was diagnosed with neuropsychiatric lupus, showing various severe symptoms and abnormal lab results.

Long-term glucocorticoid use can cause skin problems like easy bruising and poor wound healing, especially at higher doses.